News

Medindia11m
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease
Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjögren's disease. Both trials met the primary endpoint of ...
The Manila Times on MSN4h
Kris Aquino to undergo six-month isolation
Kris Aquino announced Monday she will enter a six-month preventive isolation period as part of her treatment for multiple ...
Novartis Pharma AG: Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren's ...
MMJ International Holdings: TERRY COLE FIX IT! DEA Blocks FDA Cannabis Trials While Contaminated Marijuana Floods State Markets
Reformer or Cover-Up Artist? New DEA Administrator Terrance Cole stands at a crossroads:Break rank, clean house, and restore the DEA's marijuana research credibility by approving ...
Low vitamin D symptom: Doctor reveals the silent and 'dangerous' symptom no one talks about
Vitamin D is sometimes nicknamed the “sunshine vitamin” because your skin makes it when you’re out in the sun. You can also ...
The Scientist4h
Gut Microbes Cause Fibromyalgia-Like Symptoms in Mice
Transplanting gut bacteria from healthy people reduced pain associated with fibromyalgia in mice and patients, offering a ...